These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13511356)

  • 1. A study of the serum properdin levels of patients with malignant tumors.
    ROTTINO A; LEVY AL; CONTE A
    Cancer; 1958; 11(2):351-6. PubMed ID: 13511356
    [No Abstract]   [Full Text] [Related]  

  • 2. [The properdin level in neoplasms and in malignant blood diseases].
    DIOMEDE-FRESA V; FUMAROLA A
    Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
    SZABO IK
    Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of properdin in patients with carcinoma.
    MYERBURG RJ
    Am J Clin Pathol; 1959 May; 31(5):415-8. PubMed ID: 13649635
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum-properdin levels in patients with Hodgkin's disease and carcinoma.
    ROTTINO A; LEVY AL
    Cancer; 1957; 10(5):877-83. PubMed ID: 13472632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas].
    MODICA F; FUMAROLA D
    Tumori; 1958; 44(6):549-54. PubMed ID: 13635873
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum properdin levels and cancer cell homografts in man.
    SOUTHAM CM; PILLEMER L
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):596-601. PubMed ID: 13505801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Properdin and cancer].
    MARQUES P; SALVADOR R; DOUSTE-BLAZY L; LLOVERAS J; PUEL
    Toulouse Med; 1961 Sep; 62():553-84. PubMed ID: 14470154
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interrelations of zymosan, properdin & tumors. IV. Behavior of mucopolysaccharides in the blood in benzopyrene sarcoma-bearing rats].
    MODICA F
    Tumori; 1959; 45(1):54-9. PubMed ID: 13659610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variations of properdin in cancer patients].
    MARQUES P; DOUSTE-BLAZY L; LLOVERAS J; PUEL J
    Bull Assoc Fr Etud Cancer; 1960; 47():479-87. PubMed ID: 13767080
    [No Abstract]   [Full Text] [Related]  

  • 12. Bactericidal effect of serum from normal chickens and chickens with Rous sarcoma.
    HERNBERG S
    Ann Med Exp Biol Fenn; 1961; 39():251-8. PubMed ID: 13906763
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of properdin levels in general medical and hematologic patients.
    CARLISLE HN; SASLAW S
    Am J Med Sci; 1961 Sep; 242():271-8. PubMed ID: 13690813
    [No Abstract]   [Full Text] [Related]  

  • 14. Properdin assay and levels in various blood diseases.
    HUNTER D; HILL JM
    Am J Clin Pathol; 1958 Feb; 29(2):128-34. PubMed ID: 13508614
    [No Abstract]   [Full Text] [Related]  

  • 15. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
    Dobrek Z; Majewski S; Maciejewski B
    Pol Tyg Lek; 1972 Jul; 27(24):905-8. PubMed ID: 5040537
    [No Abstract]   [Full Text] [Related]  

  • 17. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "properdin system" and some stomatological diseases. VI. Relation between the serum properdin titer and malignant epithelial neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():657-9. PubMed ID: 14480071
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in serum properdin of mice during tumor growth and following immunization to Ehrlich ascites carcinoma.
    TROEH MR; SLATER CR; LARSON WM; McKEE RW
    Proc Soc Exp Biol Med; 1962 Jan; 109():51-4. PubMed ID: 13922547
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of bladder tumors among benzidine workers and their serum properdin levels.
    Horton AW; Bingham EL
    J Natl Cancer Inst; 1977 May; 58(5):1225-8. PubMed ID: 857024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.